+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas



Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas



Cancer 94(1): 219-227, January 1



BACKGROUND. Although it is believed that p53 suppressor gene mutations, compared with mutations in the K-ras oncogene, occur at a later stage of colorectal tumorigenesis, the distribution of these genetic alterations at an early stage remains poorly characterized. METHODS. The authors analyzed the immunoreactivity for p53 protein (p53 protein expression), which reflects the functionally altered p53 gene, and K-ras mutations of codons 12 in 68 colorectal adenomas with both low-grade and high-grade dysplasia obtained from 62 patients. RESULTS. The prevalence of p53 positive immunostaining was significantly greater compared with the prevalence of K-ras mutations both in low-grade dysplasia and in high-grade dysplasia. Twenty-two adenomas (32.3%) showed positive immunostaining for p53 protein in high-grade dysplasia and also were positive for p53 in surrounding low-grade dysplastic tissues; 20 adenomas (29.4%) showed positive immunostaining for p53 protein in high-grade dysplasia and were negative for p53 in surrounding low-grade dysplastic tissues; 8 adenomas (11.7%) showed negative immunostaining for p53 protein in high-grade dysplasia and were positive for p53 in surrounding low-grade dysplastic tissues; and 18 adenomas (26.4%) showed negative immunostaining for p53 protein in both high-grade dysplasia and in surrounding low-grade dysplastic tissues. On the whole, a significant difference (P < 0.05) was seen in the frequency of p53 positive immunostaining between low-grade dysplasia and high-grade dysplasia (44.1% and 61.8%, respectively) but not in that of K-ras mutations (20.3% and 23.4%, respectively). CONCLUSIONS. The results of this study suggest that mutation of the p53 suppressor gene occurs earlier in the adenoma-carcinoma sequence than K-ras mutation, providing a clue for further understanding of the role of the p53 gene in the early stage of colorectal tumorigenesis.

(PDF emailed within 0-6 h: $19.90)

Accession: 010435983

Download citation: RISBibTeXText

PMID: 11815980

DOI: 10.1002/cncr.10198


Related references

Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 44(6): 826-833, 1999

Over-expression of p53 protein and grades of dysplasia in colorectal adenomas. Gastroenterology 104(4 SUPPL ): A446, 1993

Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas. Diseases of the Colon and Rectum 39(5): 562-567, 1996

Genetic epidemiology of altered c-K-ras protooncogene and p53 suppressor gene in colorectal adenomas. Modern Pathology 9(1): 64A, 1996

Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genetics & Cytogenetics 144(2): 112-118, July 15, 2003

Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis or colorectal adenomas. Zeitschrift für Gastroenterologie 37(8): 761-763, 1999

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. British Journal of Cancer 67(1): 88-92, 1993

"Are we ready to change our colorectal cancer screening practice?" Traditional serrated adenomas or serrated adenomas with dysplasia should be regarded as advanced adenomas with high grade dysplasia. Turkish Journal of Gastroenterology 27(5): 482-483, 2016

Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer. Genes, Chromosomes & Cancer 43(2): 162-171, 2005

Oncogene and tumor suppressor gene expression changes in the peripheral blood leukocytes of patients with colorectal cancer. Tumori 94(1): 79-82, 2008

Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas. Cancer Detection and Prevention 27(4): 297-304, 2003